Capricor Therapeutics (CAPR) Invested Capital (2010 - 2023)
Capricor Therapeutics' (CAPR) quarterly Invested Capital came in at $18628.0 in Q2 2023, down 80.21% year-on-year from $94135.0 in Q2 2022, and little changed quarter-over-quarter from $18716.0 in Q1 2023.
Capricor Therapeutics (CAPR) Invested Capital (2010 - 2023) Analysis & Trends
Capricor Therapeutics' Invested Capital history runs 8 years deep, the most recent figure standing at $18628.0 for Q2 2023.
- On a quarterly basis, Invested Capital fell 80.21% year-over-year to $18628.0 in Q2 2023; TTM through Mar 2024 was $18628.0, a 93.49% decrease from a year earlier, with the FY2022 full-year figure at $89234.0, down 85.11% from the prior year.
- Invested Capital held at $18628.0 in Q2 2023 per CAPR's latest filing, from $18716.0 in the prior quarter.
- Across five years, Invested Capital topped out at $599388.0 in Q4 2021 and bottomed at $18628.0 in Q2 2023.
- The 3-year median for Invested Capital is $89234.0 (2022), against an average of $211300.7.
- Biggest YoY gain for Invested Capital was 80.21% in 2023; the steepest drop was 96.74% in 2023.
- Year by year, Invested Capital stood at $599388.0 in 2021, then tumbled by 85.11% to $89234.0 in 2022, then plunged by 79.12% to $18628.0 in 2023.
- Per Business Quant, the three latest CAPR Invested Capital figures stand at $18628.0 (Q2 2023), $18716.0 (Q1 2023), and $89234.0 (Q4 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Capricor Therapeutics | 457.86 Mn | 457.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 18,628.00 |
| Mar 31, 2023 | 18,716.00 |
| Dec 31, 2022 | 89,234.00 |
| Sep 30, 2022 | 84,156.00 |
| Jun 30, 2022 | 94,135.00 |
| Mar 31, 2022 | 574,848.00 |
| Dec 31, 2021 | 599,388.00 |
| Sep 30, 2017 | 14.16 Mn |
| Jun 30, 2017 | 14.16 Mn |
| Dec 31, 2013 | 41,855.00 |
| Sep 30, 2013 | 18,000.00 |
| Jun 30, 2013 | 13,200.00 |
| Mar 31, 2013 | 6,600.00 |
| Dec 31, 2012 | 16,139.00 |
| Sep 30, 2012 | 8,066.00 |
| Jun 30, 2012 | 36,448.00 |
| Mar 31, 2012 | 98,291.00 |
| Dec 31, 2011 | 38,892.00 |
| Sep 30, 2011 | 36,167.00 |
| Jun 30, 2011 | 37,371.00 |